J. Dananberg

2.0k total citations · 1 hit paper
17 papers, 1.5k citations indexed

About

J. Dananberg is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J. Dananberg has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 3 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J. Dananberg's work include Nitric Oxide and Endothelin Effects (3 papers), Aldose Reductase and Taurine (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). J. Dananberg is often cited by papers focused on Nitric Oxide and Endothelin Effects (3 papers), Aldose Reductase and Taurine (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). J. Dananberg collaborates with scholars based in United States, Belgium and Canada. J. Dananberg's co-authors include Bennett G. Childs, Jan M. van Deursen, Darren J. Baker, Martina Gluscevic, Roger J. Grekin, D. A. Greene, Eva L. Feldman, Anders A. F. Sima, S. A. Lattimer and T. Thomas and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Nature Reviews Drug Discovery.

In The Last Decade

J. Dananberg

17 papers receiving 1.5k citations

Hit Papers

Senescent cells: an emerging target for diseases of ageing 2017 2026 2020 2023 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Senescent cells: an emerging target for diseases of ageing
    2017 888 citations Bennett G. Childs, Martina Gluscevic et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Dananberg United States 12 733 490 218 177 144 17 1.5k
Hema Viswambharan United Kingdom 16 631 0.9× 592 1.2× 203 0.9× 264 1.5× 395 2.7× 39 1.6k
Natacha Le Moan United States 13 1.0k 1.4× 1.1k 2.3× 174 0.8× 299 1.7× 77 0.5× 22 2.4k
Prem Gurnani United States 11 471 0.6× 858 1.8× 81 0.4× 142 0.8× 66 0.5× 20 2.5k
Yohko Yoshida Japan 23 600 0.8× 766 1.6× 211 1.0× 126 0.7× 297 2.1× 56 1.8k
Maria Teresa Gentile Italy 22 463 0.6× 534 1.1× 129 0.6× 126 0.7× 307 2.1× 59 1.7k
Anna A. Zmijewska United States 15 295 0.4× 768 1.6× 78 0.4× 85 0.5× 35 0.2× 24 1.5k
Rachel L. Matz France 19 285 0.4× 533 1.1× 277 1.3× 108 0.6× 241 1.7× 31 1.5k
Alessandra Zulian Italy 25 366 0.5× 893 1.8× 131 0.6× 105 0.6× 221 1.5× 50 1.6k
Kazuhisa Kondo Japan 23 623 0.8× 592 1.2× 136 0.6× 110 0.6× 373 2.6× 36 2.1k
Nan Mu China 24 216 0.3× 774 1.6× 168 0.8× 83 0.5× 113 0.8× 55 1.5k

Countries citing papers authored by J. Dananberg

Since Specialization
Citations

This map shows the geographic impact of J. Dananberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Dananberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Dananberg more than expected).

Fields of papers citing papers by J. Dananberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Dananberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Dananberg. The network helps show where J. Dananberg may publish in the future.

Co-authorship network of co-authors of J. Dananberg

This figure shows the co-authorship network connecting the top 25 collaborators of J. Dananberg. A scholar is included among the top collaborators of J. Dananberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Dananberg. J. Dananberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dananberg, J., Robert B. Bhisitkul, Arshad M. Khanani, et al.. (2025). Safety and Efficacy of Senolytic UBX1325 in Diabetic Macular Edema. NEJM Evidence. 4(5). EVIDoa2400009–EVIDoa2400009. 4 indexed citations
2.
Lane, N.E., et al.. (2021). A phase 2, randomized, double-blind, placebo-controlled study of senolytic molecule UBX0101 in the treatment of painful knee osteoarthritis. Osteoarthritis and Cartilage. 29. S52–S53. 28 indexed citations
3.
Dananberg, J., et al.. (2021). Predicting the placebo response in oa to improve the precision of the treatment effect estimation. Osteoarthritis and Cartilage. 29. S18–S19. 2 indexed citations
4.
Bernard, Guillaume, et al.. (2021). Leveraging historical data to optimize the number of covariates and their explained variance in the analysis of randomized clinical trials.. Statistical Methods in Medical Research. 31(2). 240–252. 7 indexed citations
5.
Hsu, Bang‐Gee, et al.. (2020). Safety, tolerability, pharmacokinetics, and clinical outcomes following treatment of painful knee osteoarthritis with senolytic molecule UBX0101. Osteoarthritis and Cartilage. 28. S479–S480. 13 indexed citations
6.
Childs, Bennett G., et al.. (2017). Senescent cells: an emerging target for diseases of ageing. Nature Reviews Drug Discovery. 16(10). 718–735. 888 indexed citations breakdown →
7.
Beasley, Charles M., Margaret O. Sowell, C. J. Carlson, et al.. (2003). Prospective evaluation of insulin sensitivity by the hyperinsulinemic, euglycemic clamp in healthy volunteers treated with olanzapine, risperidone or placebo. Schizophrenia Research. 60(1). 309–309. 7 indexed citations
8.
Sowell, Margaret O., Nitai D. Mukhopadhyay, Patrizia Cavazzoni, et al.. (2003). Evaluation of Insulin Sensitivity in Healthy Volunteers Treated with Olanzapine, Risperidone, or Placebo: A Prospective, Randomized Study Using the Two-Step Hyperinsulinemic, Euglycemic Clamp. The Journal of Clinical Endocrinology & Metabolism. 88(12). 5875–5880. 61 indexed citations
9.
Sowell, Margaret O., Nitai D. Mukhopadhyay, Patrizia Cavazzoni, et al.. (2002). Hyperglycemic Clamp Assessment of Insulin Secretory Responses in Normal Subjects Treated with Olanzapine, Risperidone, or Placebo. The Journal of Clinical Endocrinology & Metabolism. 87(6). 2918–2923. 103 indexed citations
10.
Johnson, W. Thomas, et al.. (1999). Metabolic and hemodynamic effects of moxonidine in the Zucker diabetic fatty rat model of type 2 diabetes.. Diabetes. 48(5). 1093–1100. 32 indexed citations
11.
Kanagy, Nancy L., John R. Charpie, J. Dananberg, & R. Clinton Webb. (1996). Decreased sensitivity to vasoconstrictors in aortic rings after acute exposure to nitric oxide. American Journal of Physiology-Heart and Circulatory Physiology. 271(1). H253–H260. 22 indexed citations
12.
Stevens, Martin, J. Dananberg, Eva L. Feldman, et al.. (1994). The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.. Journal of Clinical Investigation. 94(2). 853–859. 156 indexed citations
13.
Greene, D. A., Anders A. F. Sima, M. J. Stevens, et al.. (1993). Aldose reductase inhibitors: An approach to the treatment of diabetic nerve damage. Diabetes/Metabolism Reviews. 9(3). 189–217. 60 indexed citations
14.
Dananberg, J., et al.. (1993). Sustained hypertension induced by orally administered nitro-L-arginine.. Hypertension. 21(3). 359–363. 72 indexed citations
15.
Dananberg, J., et al.. (1992). Alterations in the secretion of atrial natriuretic factor in atria from aged rats.. Hypertension. 20(1). 85–88. 13 indexed citations
16.
Dananberg, J. & Roger J. Grekin. (1992). Corticoid regulation of atrial natriuretic factor secretion and gene expression. American Journal of Physiology-Heart and Circulatory Physiology. 263(5). H1377–H1381. 23 indexed citations
17.
Dananberg, J., Brent M. Egan, Eric R. Bates, & Roger J. Grekin. (1989). Sustained Saline-Induced Secretion of Atrial Natriuretic Hormone Is not Maintained by Atrial Stretch*. The Journal of Clinical Endocrinology & Metabolism. 68(4). 735–739. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hema Viswambharan Breakdown of academic impact, for papers by Natacha Le Moan Breakdown of academic impact, for papers by Prem Gurnani Breakdown of academic impact, for papers by Yohko Yoshida Breakdown of academic impact, for papers by Maria Teresa Gentile Breakdown of academic impact, for papers by Anna A. Zmijewska Breakdown of academic impact, for papers by Rachel L. Matz Breakdown of academic impact, for papers by Alessandra Zulian Breakdown of academic impact, for papers by Kazuhisa Kondo Breakdown of academic impact, for papers by Nan Mu
Rankless by CCL
2026